These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 11274642)

  • 21. Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression.
    Müller A; Trabandt A; Gloeckner-Hofmann K; Seitzer U; Csernok E; Schönermarck U; Feller AC; Gross WL
    J Pathol; 2000 Sep; 192(1):113-20. PubMed ID: 10951408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages.
    Azzawi M; Hasleton PS; Geraghty PJ; Yonan N; Krysiak P; El-Gammal A; Deiraniya AK; Hutchinson IV
    J Heart Lung Transplant; 1998 Sep; 17(9):881-7. PubMed ID: 9773860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
    Zhou Y; Huang D; Farver C; Hoffman GS
    J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of the C-class chemokine lymphotactin (XCL1) in Wegener's granulomatosis.
    Blaschke S; Brandt P; Wessels JT; Müller GA
    J Rheumatol; 2009 Nov; 36(11):2491-500. PubMed ID: 19797511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis.
    Coulomb-L'Hermine A; Capron F; Zou W; Piard F; Galateau F; Laurent P; Crevon MC; Galanaud P; Emilie D
    Hum Pathol; 2001 Mar; 32(3):320-6. PubMed ID: 11274642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production.
    Voswinkel J; Müller A; Lamprecht P
    Ann N Y Acad Sci; 2005 Jun; 1051():12-9. PubMed ID: 16126940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-lymphocytes and disease mechanisms in Wegener's granulomatosis.
    Hua F; Wilde B; Dolff S; Witzke O
    Kidney Blood Press Res; 2009; 32(6):389-98. PubMed ID: 19907189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis.
    Lamprecht P; Bruhl H; Erdmann A; Holl-Ulrich K; Csernok E; Seitzer U; Mack M; Feller AC; Reinhold-Keller E; Gross WL; Muller A
    Clin Immunol; 2003 Jul; 108(1):1-7. PubMed ID: 12865065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of RANTES expression in T lymphocytes.
    Song A; Nikolcheva T; Krensky AM
    Immunol Rev; 2000 Oct; 177():236-45. PubMed ID: 11138780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching gears during T-cell maturation: RANTES and late transcription.
    Ortiz BD; Nelson PJ; Krensky AM
    Immunol Today; 1997 Oct; 18(10):468-71. PubMed ID: 9357137
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.